This digital series highlights the mechanistic rationale behind use of tumor-infiltrating lymphocytes in solid tumors, including NSCLC, and addresses the possible challenges and benefits of this treatment approach.
EP. 1: Where Will Tumor-Infiltrating Lymphocyte (TIL) Therapy Fit Into the Oncologic Landscape?
In the first installment of the series, Allison Betof Warner, MD, PhD, reviews the mechanistic rationale behind tumor-infiltrating lymphocytes and considers where these experimental therapies may fit in the oncologic landscape.
EP. 2: Role of Tumor-Infiltrating Lymphocytes in Solid Tumors: Advancements in Therapeutic Strategy
In the first interview of this series, Allison Betof Warner, MD, PhD, reviews the mechanistic rationale of tumor-infiltrating lymphocytes and considers their potential use in the management of solid tumors.
EP. 3: TIL Therapy as a Personalized Treatment Strategy for NSCLC
EP. 4: Clinical Trials of TIL Therapy
EP. 5: Clinical Trial Data on TILs in Non-Small Cell Lung Cancer (NSCLC)
In the second installment of the series, Ben Creelan, MD, reviews clinical trial data and explains the rationale of using tumor-infiltrating lymphocytes (TILs) in non-small cell lung cancer (NSCLC) treatment.
EP. 6: Tumor-Infiltrating Lymphocytes: Rationale for Use in the Treatment of Solid Tumors and Potential Benefits and Drawbacks
In the second interview of this series, Ben Creelan, MD, Associate Member at the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida, reviews clinical trial data and explains the rationale of using tumor-infiltrating lymphocytes (TILs) in non-small cell lung cancer (NSCLC) treatment.
EP. 7: Tumor Infiltrating Lymphocyte Data Signal Promise for New Options to Treat Advanced Melanoma
In an interview with Targeted Oncology, Ryan J. Sullivan, MD, discussed the history of tumor infiltrating lymphocyte therapy, how new data may lead to approved agents in the future, and other ways tumor infiltrating lymphocytes may be used in advanced melanoma.
2 Clarke Drive Cranbury, NJ 08512